Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This observational study is following people with depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at define visual frailty and refine monitoring for an ageing population for people with depression or anxiety. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at whether a digital support tool can help people with Elderly Depression or Sleep Disturbance. Participants take part in the program and complete follow-up questionnaires or assessments.
This observational study is following people with Healthy, Depression, or Mental Health Issue to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This observational study is following people with Clinical High Risk, Psychosis, Remission, or Conversion to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at care and outcomes for people with Stress. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This observational study is following people with Inflammatory Bowel Diseases or Mental Health Issue to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at whether a digital support tool can help people with Mental Health, Oral Health Care, or Psychosis. Participants receive advice and support from a mental health professional about oral health and daily oral hygiene.
This study is looking at whether Xanomeline and Trospium Chloride Capsules can help people with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This study is comparing NBI-1117570 with placebo for people with Schizophrenia. Participants receive NBI-1117570 or placebo and complete study visits and assessments.
This study is looking at whether Cannabidiol (CBD) can help people with Clinical High Risk for Psychosis or Clinical High Risk for Developing Psychosis. Participants take part in Cannabidiol (CBD) and complete follow-up assessments.
This study is looking at be the first to comprehensively examine the health impact of social isolation in SZ for people with Schizophrenia and Related Disorders. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is comparing Diroximel fumarate (DRF) with placebo for people with Schizophrenia Disorders. Participants receive Diroximel fumarate (DRF) or placebo and complete study visits and assessments.
This study is looking at whether Personalised medication advice based on pharmacogenetic testing can help people with anxiety or psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This observational study is looking at how a digital support tool works for people with Schizophrenia Spectrum and Other psychosis or Affective Psychoses in routine care. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at care and outcomes for people with Treatment Resistant Psychosis or Psychosis. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Psychosis, First Episode Psychosis, or Psychotic Episode. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether questionnaires and follow-up can help people with Psychosis or Schizophrenia Spectrum Disorders. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at whether cognitive behavioural therapy can help people with Psychosis, Cannabis Use Disorder, or First Episode Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether a digital support tool can help people with First Episode Psychosis or Psychosis. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at whether a digital support tool can help people with Schizophrenia and Related Disorders or Early Treatment-Resistance. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at compare brain glutamate, glucose utilisation, lactate production and brain activity in healthy volunteers and people with a diagnosis of schizophrenia. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Taking part may give some people access to KarXT, but direct benefit is not guaranteed.